Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cidara Therapeutics Inc shares valued at $14,085 were sold by Tari Leslie on Mar 11 ’24. At $0.67 per share, Tari Leslie sold 21,029 shares. The insider’s holdings dropped to 258,681 shares worth approximately $0.22 million following the completion of this transaction.
Also, Sandison Taylor sold 20,662 shares, netting a total of over 13,839 in proceeds. Following the sale of shares at $0.67 each, the insider now holds 347,095 shares.
Before that, Ward Shane had sold 20,473 shares from its account. In a trade valued at $13,713, the COO & CLO traded Cidara Therapeutics Inc shares for $0.67 each. Upon closing the transaction, the insider’s holdings decreased to 20,473 shares, worth approximately $0.17 million.
Analysts at WBB Securities upgraded the stock from ‘”a Buy”‘ to ‘”a Strong buy”‘ outlook in a report released in late September. As of March 04, 2021, Aegis Capital has initiated its “Buy” rating for CDTX. Earlier on September 04, 2019, Wedbush upgraded its rating. Their new recommendation was “an Outperform” for CDTX stock which previously was a “a Neutral”.
Analyzing CDTX Stock Performance
During the last five days, there has been a drop of approximately -19.99%. Over the course of the year, Cidara Therapeutics Inc shares have jumped approximately 8.83%. Shares of the company reached a 52-week high of $1.2200 on 04/03/24 and a 52-week low of $0.6250 on 02/01/24. A 50-day SMA is recorded $0.7622, while a 200-day SMA reached $0.8487. Nevertheless, trading volume fell to 0.52 million shares from 1.69 million shares the previous day.
Support And Resistance Levels for Cidara Therapeutics Inc (CDTX)
According to the 24-hour chart, there is a support level at 0.8028, which, if violated, would cause prices to drop to 0.7416. In the upper region, resistance lies at 0.9426. The next price resistance is at 1.0212. RSI (Relative Strength Index) is 50.05 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0481, which suggests the price will decrease in the coming days. Percent R is at 71.18%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Cidara Therapeutics Inc subject to short interest?
Stocks of Cidara Therapeutics Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by -0.28 million shares to 0.18 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 0.46 million shares. A decline of -158.16% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.41 of the overall float, the days-to-cover ratio (short ratio) decline to 0.41.
